Stay updated on CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial page.

Latest updates to the CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies site revision v3.8.1 instead of v3.8.0.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe footer’s site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check33 days agoChange DetectedA sitewide NIH banner announces the transition from “Artificial Intelligence” to “Super Intelligence,” and the website revision number changes from v3.7.1 to v3.7.2.SummaryDifference0.5%

- Check47 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision entry v3.7.0 has been added to the study's history, and the previous revision v3.6.6 is removed from the visible change set.SummaryDifference0.1%

- Check82 days agoChange DetectedA new revision entry v3.6.6 was added to the study record history, replacing the previous v3.6.5. This reflects a metadata update to the record rather than a change to core study content.SummaryDifference0.1%

Stay in the know with updates to CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CMP-001 and Nivolumab in Advanced Melanoma Clinical Trial page.